From: Innovation by patients with rare diseases and chronic needs
(1) | (2) | (3) | |
---|---|---|---|
Non-restricted sample | Restricted sample | ||
Patient innovation | Solution sharing | Solution sharing | |
Disease prevalence | 0.15 (0.15) | −0.13 (0.16) | −0.11 (0.20) |
Disease burden | 0.27** (0.13) | 0.12 (0.14) | 0.09 (0.19) |
Respondent’s Age | 0.13 (0.09) | 0.25** (0.1) | 0.21** (0.11) |
Respondent’s Age squared | −0.002* (0.0) | −0.002** (0.0) | −0.002* (0.001) |
Disease Duration | 0.02 (0.05) | −0.07* (0.04) | −0.13*** (0.05) |
Disease Duration squared | −0.001 (0.0) | 0.002* (0.0) | 0.002*** (0.001) |
Gender | −0.51 (0.42) | −0.25 (0.49) | −0.29 (0.55) |
Academic Degree | 0.68** (0.3) | 0.33 (0.27) | 0.37 (0.30) |
Employment status | −0.05 (0.38) | −0.13 (0.36) | 0.41 (0.44) |
Marital status | 0.66 (0.4) | −0.01 (0.36) | −0.25 (0.45) |
Medical patient community membership | 0.39 (0.43) | 0.29 (0.44) | 0.30 (0.51) |
Improvement in overall quality of life (before-after solution use) | 0.52*** (0.11) | 0.55*** (0.15) | |
Constant | −7.26*** (2.2) | −7.58*** (2.4) | −7.53*** (2.54) |
Observations | 485 | 231 | 159 |
Chi2 | 28.8 | 39.1 | 27.3 |
McFaden’s pseudo R2 | 0.08 | 0.16 | 0.18 |
c-statistics | 0.72 | 0.77 | 0.77 |